We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+30.38%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$25.8M
Cap. Flow
-$11.5M
Cap. Flow %
-6.46%
Top 10 Hldgs %
49.87%
Holding
82
New
15
Increased
17
Reduced
25
Closed
12

Top Buys

Rank Stock Value
1
XNCR icon
Xencor
XNCR
+$3.26M
2
ESPR
Esperion Therapeutics
ESPR
+$1.11M
3
VZ icon
Verizon
VZ
+$984K
4
GLD icon
SPDR Gold Trust
GLD
+$806K
5
TGT icon
Target
TGT
+$571K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.14M
2
XYZ
Block Inc
XYZ
+$1.05M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$740K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$639K
5
GM icon
General Motors
GM
+$623K

Sector Composition

Rank Sector Weight
1 Healthcare 37.61%
2 Technology 13.76%
3 Communication Services 9.15%
4 Financials 5.23%
5 Consumer Discretionary 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLNX
26
DELISTED
Xilinx Inc
XLNX
$2.21M 1.24%
22,500
-2,500
-10% -$222K
AOD
27
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.19M 1.23%
284,917
-5,000
-2% -$36.4K
GDXJ icon
28
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$2.11M 1.18%
42,500
+7,500
+21% +$318K
GLD icon
29
CALL
SPDR Gold Trust
GLD
$131B
$2.09M 1.17%
+12,500
New +$2.02M
BRK.B icon
30
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.05M 1.15%
11,500
-3,500
-23% -$639K
LOW icon
31
Lowe's Companies
LOW
$117B
$1.69M 0.95%
12,500
+1,500
+14% +$171K
ALXN
32
DELISTED
Alexion Pharmaceuticals
ALXN
$1.46M 0.82%
13,000
+4,000
+44% +$425K
AMRN
33
Amarin Corp
AMRN
$298M
$1.34M 0.75%
9,663
-537
-5% -$73.9K
MU icon
34
CALL
Micron Technology
MU
$930B
$1.29M 0.72%
+25,000
New +$1.18M
ORCL icon
35
CALL
Oracle
ORCL
$374B
$1.24M 0.7%
+22,500
New +$1.19M
CSCO icon
36
Cisco
CSCO
$457B
$1.17M 0.65%
25,000
-7,500
-23% -$329K
INCY icon
37
CALL
Incyte
INCY
$24.2B
$1.04M 0.58%
+10,000
New +$964K
BOX icon
38
Box
BOX
$4.37B
$1.04M 0.58%
50,000
+10,000
+25% +$176K
ARNA
39
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.01M 0.56%
16,000
-500
-3% -$27.5K
NKTR icon
40
Nektar Therapeutics
NKTR
$2.39B
$996K 0.56%
2,867
– –
NOK icon
41
Nokia
NOK
$51B
$946K 0.53%
215,000
+65,000
+43% +$246K
IBM icon
42
IBM
IBM
$211B
$906K 0.51%
7,845
– –
INTC icon
43
Intel
INTC
$455B
$897K 0.5%
15,000
+5,000
+50% +$299K
STEW
44
SRH Total Return Fund
STEW
$1.79B
$835K 0.47%
88,683
+29,900
+51% +$283K
GDX icon
45
CALL
VanEck Gold Miners ETF
GDX
$22.7B
$825K 0.46%
+22,500
New +$740K
GEN icon
46
Gen Digital
GEN
$16.4B
$793K 0.44%
40,000
– –
APTV icon
47
Aptiv
APTV
$12B
$779K 0.44%
10,000
-2,500
-20% -$172K
C icon
48
PUT
Citigroup
C
$222B
$767K 0.43%
+15,000
New +$712K
AAPL icon
49
Apple
AAPL
$4.54T
$730K 0.41%
8,000
-2,000
-20% -$155K
SGMO
50
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$631K 0.35%
70,400
+16,500
+31% +$153K
1
2
3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, DCF Advisers held 82 positions worth $179M, up 17% from $153M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers withdrew a net $11.5M in Q2 2020, closing 12 positions and reducing 25 holdings. Its most notable exit was Block Inc, an estimated $1.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Target worth $600K.

  • DCF Advisers's largest Q2 2020 buy was Target: 5,000 shares worth $600K.
  • DCF Advisers added most to Xencor in Q2 2020, an estimated $3.26M increase.
  • DCF Advisers's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.14M.
  • DCF Advisers fully exited Block Inc in Q2 2020, selling an estimated $1.05M.
  • DCF Advisers's ten largest holdings make up 50% of its $179M portfolio in Q2 2020.
  • DCF Advisers opened 15 new positions and closed 12 in Q2 2020.
  • DCF Advisers's portfolio value rose 17% quarter-over-quarter to $179M.

Based on DCF Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.